Andrew Conrad
Founder at National Genetics Institute, Inc.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Lawrence Cary Gunn | M | - |
Genalyte, Inc.
Genalyte, Inc. Medical SpecialtiesHealth Technology Genalyte, Inc. specializes in instrumentation and multiplex assays for biomarker and protein detection. The firm offers autoantibody testing assays for autoimmune research, custom assay services and maverick detection system. The company was founded in 2007 by Lawrence Cary Gunn III and is headquartered in San Diego, CA. | 17 years |
Svilen Ivanov Karaivanov | M | 44 |
Lynx Design, Inc.
Lynx Design, Inc. Electronics/AppliancesConsumer Durables Lynx Design, Inc. manufactures mechanical spoon. The company was founded by Anupam Pathak and is headquartered in Mountain View, CA. | - |
Jeffrey Huber | M | 55 |
Genalyte, Inc.
Genalyte, Inc. Medical SpecialtiesHealth Technology Genalyte, Inc. specializes in instrumentation and multiplex assays for biomarker and protein detection. The firm offers autoantibody testing assays for autoimmune research, custom assay services and maverick detection system. The company was founded in 2007 by Lawrence Cary Gunn III and is headquartered in San Diego, CA. | 5 years |
Andrew Harrison | M | - |
Section 32 LLC
Section 32 LLC Investment ManagersFinance Section 32 LLC (Section 32) is a venture capital firm founded in 2017 by Bill Maris. The firm is headquartered in Silicon Valley, California. | 3 years |
Arun Sridhar | M | - |
Galvani Bioelectronics Ltd.
Galvani Bioelectronics Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Galvani Bioelectronics Ltd. is a pioneering research and British development company founded in 2016, dedicated to bringing bioelectronic therapies to patients. The company is based in Stevenage, UK. Galvani Bioelectronics combines GSK's therapeutics discovery and development knowledge with Verily's expertise in software and electronics for clinical applications. The company is developing therapies through implant-based direct modulation of specific neural signals to organs central in disease. These therapies are designed to be safe, precise in their therapeutic effect, and minimally invasive in their delivery through the use of small and efficient wireless electronics and keyhole surgery. Connected software will ensure that patients and physicians can effectively control and optimize the therapy. | - |
Nick Smith | M | - |
Section 32 LLC
Section 32 LLC Investment ManagersFinance Section 32 LLC (Section 32) is a venture capital firm founded in 2017 by Bill Maris. The firm is headquartered in Silicon Valley, California. | 2 years |
Nina Labatt | F | - |
Section 32 LLC
Section 32 LLC Investment ManagersFinance Section 32 LLC (Section 32) is a venture capital firm founded in 2017 by Bill Maris. The firm is headquartered in Silicon Valley, California. | 3 years |
Christopher Corsico | M | 62 |
Galvani Bioelectronics Ltd.
Galvani Bioelectronics Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Galvani Bioelectronics Ltd. is a pioneering research and British development company founded in 2016, dedicated to bringing bioelectronic therapies to patients. The company is based in Stevenage, UK. Galvani Bioelectronics combines GSK's therapeutics discovery and development knowledge with Verily's expertise in software and electronics for clinical applications. The company is developing therapies through implant-based direct modulation of specific neural signals to organs central in disease. These therapies are designed to be safe, precise in their therapeutic effect, and minimally invasive in their delivery through the use of small and efficient wireless electronics and keyhole surgery. Connected software will ensure that patients and physicians can effectively control and optimize the therapy. | - |
Brian Patrick Otis | M | 47 |
Galvani Bioelectronics Ltd.
Galvani Bioelectronics Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Galvani Bioelectronics Ltd. is a pioneering research and British development company founded in 2016, dedicated to bringing bioelectronic therapies to patients. The company is based in Stevenage, UK. Galvani Bioelectronics combines GSK's therapeutics discovery and development knowledge with Verily's expertise in software and electronics for clinical applications. The company is developing therapies through implant-based direct modulation of specific neural signals to organs central in disease. These therapies are designed to be safe, precise in their therapeutic effect, and minimally invasive in their delivery through the use of small and efficient wireless electronics and keyhole surgery. Connected software will ensure that patients and physicians can effectively control and optimize the therapy. | - |
Kristoffer Famm | M | - |
Galvani Bioelectronics Ltd.
Galvani Bioelectronics Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Galvani Bioelectronics Ltd. is a pioneering research and British development company founded in 2016, dedicated to bringing bioelectronic therapies to patients. The company is based in Stevenage, UK. Galvani Bioelectronics combines GSK's therapeutics discovery and development knowledge with Verily's expertise in software and electronics for clinical applications. The company is developing therapies through implant-based direct modulation of specific neural signals to organs central in disease. These therapies are designed to be safe, precise in their therapeutic effect, and minimally invasive in their delivery through the use of small and efficient wireless electronics and keyhole surgery. Connected software will ensure that patients and physicians can effectively control and optimize the therapy. | - |
Jordi Parramon | M | - |
Galvani Bioelectronics Ltd.
Galvani Bioelectronics Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Galvani Bioelectronics Ltd. is a pioneering research and British development company founded in 2016, dedicated to bringing bioelectronic therapies to patients. The company is based in Stevenage, UK. Galvani Bioelectronics combines GSK's therapeutics discovery and development knowledge with Verily's expertise in software and electronics for clinical applications. The company is developing therapies through implant-based direct modulation of specific neural signals to organs central in disease. These therapies are designed to be safe, precise in their therapeutic effect, and minimally invasive in their delivery through the use of small and efficient wireless electronics and keyhole surgery. Connected software will ensure that patients and physicians can effectively control and optimize the therapy. | - |
Kenzo Fong | M | - |
Section 32 LLC
Section 32 LLC Investment ManagersFinance Section 32 LLC (Section 32) is a venture capital firm founded in 2017 by Bill Maris. The firm is headquartered in Silicon Valley, California. | - |
Ainhoa Maiz | F | - |
Section 32 LLC
Section 32 LLC Investment ManagersFinance Section 32 LLC (Section 32) is a venture capital firm founded in 2017 by Bill Maris. The firm is headquartered in Silicon Valley, California. | 2 years |
Rami El Assal | M | - |
Genalyte, Inc.
Genalyte, Inc. Medical SpecialtiesHealth Technology Genalyte, Inc. specializes in instrumentation and multiplex assays for biomarker and protein detection. The firm offers autoantibody testing assays for autoimmune research, custom assay services and maverick detection system. The company was founded in 2007 by Lawrence Cary Gunn III and is headquartered in San Diego, CA. | 1 years |
Amy Altshul | F | - |
Galvani Bioelectronics Ltd.
Galvani Bioelectronics Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Galvani Bioelectronics Ltd. is a pioneering research and British development company founded in 2016, dedicated to bringing bioelectronic therapies to patients. The company is based in Stevenage, UK. Galvani Bioelectronics combines GSK's therapeutics discovery and development knowledge with Verily's expertise in software and electronics for clinical applications. The company is developing therapies through implant-based direct modulation of specific neural signals to organs central in disease. These therapies are designed to be safe, precise in their therapeutic effect, and minimally invasive in their delivery through the use of small and efficient wireless electronics and keyhole surgery. Connected software will ensure that patients and physicians can effectively control and optimize the therapy. | 3 years |
Wesley Tillu | M | - |
Section 32 LLC
Section 32 LLC Investment ManagersFinance Section 32 LLC (Section 32) is a venture capital firm founded in 2017 by Bill Maris. The firm is headquartered in Silicon Valley, California. | 3 years |
Kimberly Shih | F | - |
Section 32 LLC
Section 32 LLC Investment ManagersFinance Section 32 LLC (Section 32) is a venture capital firm founded in 2017 by Bill Maris. The firm is headquartered in Silicon Valley, California. | - |
Alice Cheung | F | - |
Section 32 LLC
Section 32 LLC Investment ManagersFinance Section 32 LLC (Section 32) is a venture capital firm founded in 2017 by Bill Maris. The firm is headquartered in Silicon Valley, California. | 4 years |
Adam Roth | M | - |
Galvani Bioelectronics Ltd.
Galvani Bioelectronics Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Galvani Bioelectronics Ltd. is a pioneering research and British development company founded in 2016, dedicated to bringing bioelectronic therapies to patients. The company is based in Stevenage, UK. Galvani Bioelectronics combines GSK's therapeutics discovery and development knowledge with Verily's expertise in software and electronics for clinical applications. The company is developing therapies through implant-based direct modulation of specific neural signals to organs central in disease. These therapies are designed to be safe, precise in their therapeutic effect, and minimally invasive in their delivery through the use of small and efficient wireless electronics and keyhole surgery. Connected software will ensure that patients and physicians can effectively control and optimize the therapy. | 6 years |
Subesh Williams | M | 62 |
Galvani Bioelectronics Ltd.
Galvani Bioelectronics Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Galvani Bioelectronics Ltd. is a pioneering research and British development company founded in 2016, dedicated to bringing bioelectronic therapies to patients. The company is based in Stevenage, UK. Galvani Bioelectronics combines GSK's therapeutics discovery and development knowledge with Verily's expertise in software and electronics for clinical applications. The company is developing therapies through implant-based direct modulation of specific neural signals to organs central in disease. These therapies are designed to be safe, precise in their therapeutic effect, and minimally invasive in their delivery through the use of small and efficient wireless electronics and keyhole surgery. Connected software will ensure that patients and physicians can effectively control and optimize the therapy. | 8 years |
Gerard van Hamel Platerink | M | - |
Genalyte, Inc.
Genalyte, Inc. Medical SpecialtiesHealth Technology Genalyte, Inc. specializes in instrumentation and multiplex assays for biomarker and protein detection. The firm offers autoantibody testing assays for autoimmune research, custom assay services and maverick detection system. The company was founded in 2007 by Lawrence Cary Gunn III and is headquartered in San Diego, CA. | - |
Bradford Hirsch | M | - |
Galvani Bioelectronics Ltd.
Galvani Bioelectronics Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Galvani Bioelectronics Ltd. is a pioneering research and British development company founded in 2016, dedicated to bringing bioelectronic therapies to patients. The company is based in Stevenage, UK. Galvani Bioelectronics combines GSK's therapeutics discovery and development knowledge with Verily's expertise in software and electronics for clinical applications. The company is developing therapies through implant-based direct modulation of specific neural signals to organs central in disease. These therapies are designed to be safe, precise in their therapeutic effect, and minimally invasive in their delivery through the use of small and efficient wireless electronics and keyhole surgery. Connected software will ensure that patients and physicians can effectively control and optimize the therapy. | 3 years |
Robert Gunderson | M | 72 |
Section 32 LLC
Section 32 LLC Investment ManagersFinance Section 32 LLC (Section 32) is a venture capital firm founded in 2017 by Bill Maris. The firm is headquartered in Silicon Valley, California. | - |
Andy Conrad | - | - |
Section 32 LLC
Section 32 LLC Investment ManagersFinance Section 32 LLC (Section 32) is a venture capital firm founded in 2017 by Bill Maris. The firm is headquartered in Silicon Valley, California. | - |
Rajesh Swaminathan | M | - |
Genalyte, Inc.
Genalyte, Inc. Medical SpecialtiesHealth Technology Genalyte, Inc. specializes in instrumentation and multiplex assays for biomarker and protein detection. The firm offers autoantibody testing assays for autoimmune research, custom assay services and maverick detection system. The company was founded in 2007 by Lawrence Cary Gunn III and is headquartered in San Diego, CA. | - |
William Maris | M | - |
Section 32 LLC
Section 32 LLC Investment ManagersFinance Section 32 LLC (Section 32) is a venture capital firm founded in 2017 by Bill Maris. The firm is headquartered in Silicon Valley, California. | 7 years |
Steven Kafka | M | 54 |
Section 32 LLC
Section 32 LLC Investment ManagersFinance Section 32 LLC (Section 32) is a venture capital firm founded in 2017 by Bill Maris. The firm is headquartered in Silicon Valley, California. | 5 years |
Rufus W. Burlingame | M | - |
Genalyte, Inc.
Genalyte, Inc. Medical SpecialtiesHealth Technology Genalyte, Inc. specializes in instrumentation and multiplex assays for biomarker and protein detection. The firm offers autoantibody testing assays for autoimmune research, custom assay services and maverick detection system. The company was founded in 2007 by Lawrence Cary Gunn III and is headquartered in San Diego, CA. | 11 years |
Joe Markee | M | 70 |
Genalyte, Inc.
Genalyte, Inc. Medical SpecialtiesHealth Technology Genalyte, Inc. specializes in instrumentation and multiplex assays for biomarker and protein detection. The firm offers autoantibody testing assays for autoimmune research, custom assay services and maverick detection system. The company was founded in 2007 by Lawrence Cary Gunn III and is headquartered in San Diego, CA. | - |
David Friedberg | M | 44 |
Section 32 LLC
Section 32 LLC Investment ManagersFinance Section 32 LLC (Section 32) is a venture capital firm founded in 2017 by Bill Maris. The firm is headquartered in Silicon Valley, California. | - |
Saeid Akhtari | M | - |
Genalyte, Inc.
Genalyte, Inc. Medical SpecialtiesHealth Technology Genalyte, Inc. specializes in instrumentation and multiplex assays for biomarker and protein detection. The firm offers autoantibody testing assays for autoimmune research, custom assay services and maverick detection system. The company was founded in 2007 by Lawrence Cary Gunn III and is headquartered in San Diego, CA. | - |
Michael Pellini | M | 58 |
Section 32 LLC
Section 32 LLC Investment ManagersFinance Section 32 LLC (Section 32) is a venture capital firm founded in 2017 by Bill Maris. The firm is headquartered in Silicon Valley, California. | 7 years |
Gerard van Hamel Platerink | M | 55 |
Genalyte, Inc.
Genalyte, Inc. Medical SpecialtiesHealth Technology Genalyte, Inc. specializes in instrumentation and multiplex assays for biomarker and protein detection. The firm offers autoantibody testing assays for autoimmune research, custom assay services and maverick detection system. The company was founded in 2007 by Lawrence Cary Gunn III and is headquartered in San Diego, CA. | 2 years |
Ken Gabriel | M | 68 |
Galvani Bioelectronics Ltd.
Galvani Bioelectronics Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Galvani Bioelectronics Ltd. is a pioneering research and British development company founded in 2016, dedicated to bringing bioelectronic therapies to patients. The company is based in Stevenage, UK. Galvani Bioelectronics combines GSK's therapeutics discovery and development knowledge with Verily's expertise in software and electronics for clinical applications. The company is developing therapies through implant-based direct modulation of specific neural signals to organs central in disease. These therapies are designed to be safe, precise in their therapeutic effect, and minimally invasive in their delivery through the use of small and efficient wireless electronics and keyhole surgery. Connected software will ensure that patients and physicians can effectively control and optimize the therapy. | - |
Ashraf Hanna | M | 56 |
Genalyte, Inc.
Genalyte, Inc. Medical SpecialtiesHealth Technology Genalyte, Inc. specializes in instrumentation and multiplex assays for biomarker and protein detection. The firm offers autoantibody testing assays for autoimmune research, custom assay services and maverick detection system. The company was founded in 2007 by Lawrence Cary Gunn III and is headquartered in San Diego, CA. | - |
Seema Bhan | F | - |
Section 32 LLC
Section 32 LLC Investment ManagersFinance Section 32 LLC (Section 32) is a venture capital firm founded in 2017 by Bill Maris. The firm is headquartered in Silicon Valley, California. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
David A. DeLorenzo | M | 76 | 43 years | |
Richard Dahl | M | 72 | 5 years | |
E. Rolland Dickson | M | 90 | - | |
Justin M. Murdock | M | 51 | 10 years | |
Michael Aicher | M | 64 |
National Genetics Institute, Inc.
National Genetics Institute, Inc. Chemicals: SpecialtyProcess Industries Part of Laboratory Corp. of America Holdings, National Genetics Institute, Inc. provides hepatitis C testing and other laboratory services. The company is based in Los Angeles, CA. The company was founded by Andrew J. Conrad, Michael A. Aicher. National Genetics Institute was acquired by Laboratory Corp. of America Holdings on August 01, 2000. | 21 years |
Dennis Mark Weinberg | M | 71 | - | |
Bradford T. Smith | M | 70 | 14 years | |
Lawrence A. Kern | M | - | 3 years | |
Sherry Lansing | F | 79 | 4 years | |
Elaine Chao | F | 71 | 4 years | |
N. Coles | M | 63 | 2 years | |
Joseph S. Tesoriero | M | 69 | 11 years | |
Paul Kirchgraber | M | 62 | 14 years | |
Mark Brecher | M | 67 | - | |
Javier H. Idrovo | M | 57 | 7 years | |
Myla Lai-Goldman | M | 66 | 17 years | |
Edward C. Roohan | M | 61 | 6 years | |
Lawrence Blatt | M | 62 |
National Genetics Institute, Inc.
National Genetics Institute, Inc. Chemicals: SpecialtyProcess Industries Part of Laboratory Corp. of America Holdings, National Genetics Institute, Inc. provides hepatitis C testing and other laboratory services. The company is based in Los Angeles, CA. The company was founded by Andrew J. Conrad, Michael A. Aicher. National Genetics Institute was acquired by Laboratory Corp. of America Holdings on August 01, 2000. | 2 years |
Peter M. Nolan | M | - | - | |
Donnie Hardison | M | 73 | 2 years | |
Richard M. Ferry | M | 86 | 3 years | |
William B. Haas | M | 59 | 18 years | |
Mark McKinney | M | 61 | 7 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 49 | 83.05% |
United Kingdom | 10 | 16.95% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Andrew Conrad
- Personal Network